1. Home
  2. ECF vs ARCT Comparison

ECF vs ARCT Comparison

Compare ECF & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ellsworth Growth and Income Fund Ltd.

ECF

Ellsworth Growth and Income Fund Ltd.

SELL

Current Price

$11.64

Market Cap

162.7M

Sector

Finance

ML Signal

SELL

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

SELL

Current Price

$10.41

Market Cap

369.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ECF
ARCT
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.7M
369.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ECF
ARCT
Price
$11.64
$10.41
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $23.80
AVG Volume (30 Days)
52.0K
★ 736.3K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
★ 6.42%
N/A
EPS Growth
N/A
★ 20.00
EPS
★ 0.46
N/A
Revenue
N/A
★ $82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$64.21
P/E Ratio
$25.65
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$10.71
$5.50
52 Week High
$13.85
$24.14

Technical Indicators

Market Signals
Indicator
ECF
ARCT
Relative Strength Index (RSI) 35.76 36.07
Support Level $11.16 $6.53
Resistance Level $11.67 $17.85
Average True Range (ATR) 0.17 1.11
MACD -0.01 -0.42
Stochastic Oscillator 2.74 4.67

Price Performance

Historical Comparison
ECF
ARCT

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: